Hitting Zero: Is the Last Benzodiazepine Dose the End of Withdrawal?

What does hitting zero mean, and is it the end of withdrawal?

Hitting zero is the phrase patients use for the day a taper reaches its last dose. After months of small reductions, there is nothing left to reduce. Is that the end of withdrawal? For some people it nearly is. For many it is not.

Professor C. Heather Ashton described both outcomes in Chapter III of the Ashton Manual. With slow tapering, she wrote, some long-term users have “virtually lost all their symptoms by the time they take their last tablet,” and in the majority symptoms disappear within a few months. She also described a minority whose symptoms last much longer.

So, zero ends the taper. It does not end the healing. The nervous system has been adjusting at every step of a slow taper, and after the last dose it finishes that work without the medication.

The last step should feel like just another step.

How a person arrives at zero matters. The Maudsley Deprescribing Guidelines describe hyperbolic reductions, in which each step gets smaller as the dose gets lower, and they warn that going from the smallest tablet straight to zero can bring on severe withdrawal symptoms for some patients.

Professor Ashton taught from 2 mg diazepam (Valium) tablets, which can only be divided so far. In Chapter II, she advised patients to “take the plunge” at 0.5 mg a day, because “full recovery cannot begin until you have got off your tablets completely.” That remains an option for a patient who is doing well and chooses it.

However, Dr. Mark Leeds, an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, does not use it as the default. With the manufactured 1 mg/mL diazepam oral solution, he keeps reducing below 0.5 mg, in steps sized to the remaining dose, and stops at about 0.1 mg. The stopping point is agreed in advance, and these figures describe the shape of an ending, not a schedule for anyone to follow alone.

Near the bottom, the holds often get longer. A patient who stays at one dose for several weeks has not failed, and in Dr. Leeds’ practice a small updose after a cut that proves too large is a legitimate correction. A separate article covers how low a taper should go before the last dose.

Why can symptoms continue when the medication is gone?

Benzodiazepines, and z-drugs such as zolpidem (Ambien), strengthen the effect of gamma-aminobutyric acid (GABA), the brain’s main calming signal. Over months and years of daily use, the receptors adapt and respond less. Take the medication away, and the result is what Chapter III of the Manual describes: a brain and peripheral nervous system “in a hyperexcitable state, and extremely vulnerable to stress.”

That adaptation reverses slowly, and not on the day of the last dose. Anyone who has spent a week on a boat knows the feeling of stepping onto the dock and having the ground sway. The dock is not moving. The body’s sense of balance adjusted to the sea, and it needs time to adjust back.

Unfortunately, the people around a patient often draw the wrong conclusion. They see someone who seemed fine on the tablets and unwell without them, and they decide that the medication was needed for life, or that this must be addiction. It is neither.

The United States Food and Drug Administration (FDA) stated in its 2020 boxed-warning update that physical dependence can occur when benzodiazepines are taken steadily for several days to weeks, even as prescribed. Physical dependence is not addiction. It is a change in the nervous system caused by a medication taken as directed, and it heals with time.

Is it rebound, withdrawal, or the old problem coming back?

Three different things can follow the last dose, and they are easy to confuse. Rebound is the original symptom returning for a short time, stronger than it was before the medication. A person who took a sleeping pill for insomnia may have several nights worse than the ones that led to the prescription.

Withdrawal is different, because it also brings symptoms the person never had before. Chapter III of the Manual lists tinnitus, tingling, numbness, burning pain, a feeling of inner trembling, muscle cramps, and jerks among the symptoms of withdrawal. A person prescribed a benzodiazepine for poor sleep did not, as a rule, have ringing ears or burning skin beforehand.

The third possibility is the original condition returning in its old familiar pattern, without the new symptoms. It does happen. Yet, it is also the explanation patients are handed first, and hearing that it is just the old anxiety coming back, while the ears ring and the skin burns, is deeply discouraging.

So, how can they be told apart? Symptoms that were never part of the original problem, and that come and go in waves, point to withdrawal. Sorting it out is a job for the patient and the physician together, and not a verdict to reach in the middle of a bad night.

How long does healing take after the last dose?

No one can name the date, and a physician who does is guessing. Fortunately, for most people who taper slowly, the months after the last dose bring steady improvement.

A minority have symptoms that last longer, which is protracted withdrawal, and many patients and physicians now call that lasting disturbance benzodiazepine-induced neurological dysfunction (BIND). The class labeling that the FDA required in 2020 describes protracted withdrawal symptoms that persist beyond four to six weeks and may last from weeks to more than 12 months.

Table 3 of Chapter III gives the usual course: anxiety gradually diminishing over a year, insomnia over six to twelve months, and sensory symptoms, motor symptoms, and poor memory that may last at least a year and occasionally several years. Professor Ashton added that, compared with long-term users as a whole, the incidence of protracted symptoms after a slow taper under the patient’s own control is “almost certainly very much lower.”

Yet, the improvement does not arrive evenly, and patients call the pattern windows and waves. A window is a stretch of hours or days that feels close to normal, and a wave is the return of symptoms, often with no cause anyone can find.

The Manual describes the same course, with symptoms that “characteristically wax and wane” and “Windows” of normality that “become more frequent and last longer.” A wave after a good week does not mean that healing has stopped. Professor Ashton’s verdict was that “a steady decline in symptoms almost invariably continues after withdrawal, though it can take a long time.”

Why do anxiety, low mood, and irritability show up after zero?

The same overexcited nervous system that produces tingling and tinnitus also produces feelings. Anxiety that spikes without a trigger, low mood, tearfulness, and a short temper are expected effects of a nervous system that is still readjusting. They are not a character flaw, and they are not proof that a new illness has arrived.

There is a second reason. The first chapter of the Manual notes that “emotional anaesthesia,” the inability to feel pleasure or pain, is a common complaint of long-term users. When the medication is gone, feeling comes back, and after years of being muted it can come back all at once.

Table 1 of Chapter III lists rage, aggression, and irritability among the symptoms of withdrawal. Professor Ashton wrote that protracted anxiety tends to subside gradually and rarely lasts more than a year, and her Table 3 says that depression may last a few months.

So, a hard day after zero is not a personal failure. It is a symptom. A patient can extend to themselves the patience they would give a friend.

While low mood is expected, despair is not something to wait out. Depression that deepens over weeks instead of lifting deserves a medical opinion. Anyone with thoughts of suicide can call or text 988, the Suicide and Crisis Lifeline, at any hour, and a seizure or any other medical emergency is a reason to call 911.

Who is the person without the medication?

After ten or twenty years, a daily tablet becomes part of how a person describes themselves: the one who cannot sleep without it, the one who needs something to stay calm. Hitting zero takes that description away. Who is left? It is a fair question, and the first weeks after zero are the worst time to answer it.

In fact, the raw, anxious, sleepless person of those weeks is not the true self finally uncovered. That person is a nervous system recalibrating. A fair reading of who someone is without the medication has to wait until the waves have thinned out.

Professor Ashton made a related point in Chapter III. Benzodiazepines, she wrote, “specifically impair the learning of new skills, including stress-coping strategies,” and full recovery may require “many months of learning new stress-coping strategies.” She also observed that people often feel more self-confident after withdrawal than they did before the medication.

There is often grief as well, for the years that passed under the medication. That grief is a reasonable response to what happened, and a separate article looks at how a person rebuilds work and identity after a taper.

What helps after zero, and who should still be there?

The plain things help: a fixed wake time, regular meals, gentle movement, daylight, and something worth doing each day. None of them makes the nervous system readjust any faster. They make the waiting more livable.

Support should not end with the last prescription. Chapter II of the Manual advises that support be available during the taper and for some months afterwards, from a spouse, a family member, or a close friend. People who have been through withdrawal themselves can help too, because nothing has to be explained to them.

The physician belongs on that list. A doctor who considers the job finished on the day of the last dose has left early. New or severe symptoms deserve a medical opinion, and so does any thought of going back on the medication, a decision covered in the article on updosing and reinstatement.

The last dose ends the taper, and the healing continues.

So, the direction after zero is toward healing. For most people who taper slowly it takes months, for some it takes longer, and it is different for each person. What can be planned is the approach: a last step no bigger than the ones before it, and people who stay for what comes after.

Dr. Leeds’ practice is built that way. The taper is gradual and patient-directed, with a crossover taper to diazepam where a short-acting medication such as alprazolam (Xanax) or lorazepam (Ativan) makes it useful, steps that shrink as the dose falls, and a stopping point agreed in advance.

In his practice, Dr. Leeds is one physician who works directly with each patient, by telemedicine throughout Florida on a concierge basis. Contact Dr. Leeds to ask about a taper plan or about the months after one.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.